- Click for Credit
T-cell lymphoma therapies on the horizon
JOLLA, CALIF. – There are several biologic compounds in early clinical development for treatment of patients with T-cell lymphomas, including an antibody-drug conjugate, novel immune checkpoint inhibitor, and bi-specific antibody.These investigational agents show promising single-agent activity and have the potential to improve ......(full story)
Latest PANS trials suggest cause may be treatable
YORK – New controlled trials in the treatment of pediatric acute neuropsychiatric syndrome (PANS) support the hypothesis that the cause may, in fact, be treatable, an expert said at a pediatric psychopharmacology update held by the American Academy of Child and Adolescent ......(full story)
Large database analysis suggests safety of bariatric surgery in seniors
HARBOR, MD. – Gastric bypass and sleeve gastrectomy procedures for weight loss should not be denied to patients older than 60 years, despite a slight increase in unadjusted mortality rates, according to an analysis of data from the Metabolic and Bariatric Surgery ......(full story)
VA shares its best practices to achieve HCV ‘cascade of cure’
U.S. Department of Veterans Affairs (VA) cares for more patients with hepatitis C virus than any other care provider in the country, and has achieved a rapid and sharp reduction in hepatitis C virus (HCV) infection among veterans over the past 3 ......(full story)
Study shows childhood IBD increased cancer risk in adulthood
who had developed inflammatory bowel disease had an 18-fold greater risk of gastrointestinal cancers in later life, a new study suggests.The cohort study found that the risk of all cancers was elevated in individuals with childhood-onset inflammatory bowel disease, but particularly in ......(full story)
CLICK for Credit articles are peer-reviewed by Lisa Joan Pfitzer, MD, Assistant Professor, University of Louisville School of Medicine and Chair, University of Louisville Continuing Medical Education Advisory Committee. Dr. Pfitzer has no relevant financial relationships with any commercial interests. Whitney McKnight has no relevant financial relationship with any commercial interests.
Joint Providership:This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville School of Medicine and Global Academy for Medical Education. The University of Louisville is accredited by the ACCME to provide continuing education for physicians.
Designation Statement:The University of Louisville Continuing Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
More CME Information